BUZZ-China's Haisco jumps most in 8 months on Nuvectis licensing deal

Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc.

NVCT

0.00

** Shares of Haisco Pharmaceutical Group 002653.SZ jump 9.7% to 54 yuan, on track for their biggest one-day pct rise since October 31, 2025

** Stock hits the highest since June 1 in the third straight session of gains

** Nuvectis Pharma NVCT.O said on Monday it had licensed exclusive rights outside China to two experimental drugs from Haisco Pharmaceutical Group 002653.SZ, targeting complement-mediated diseases and cancer to broaden its pipeline

** Haisco will receive upfront and near-term payments totaling up to $40 million and is eligible to receive up to $1.42 billion in additional milestone payments, and tiered royalties on future net sales

** YTD, stock up 3.6%, benchmark CSI300 Index .CSI300 up 8.1%




This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.